Allergy Partners

Allergy Partners is a United States-based healthcare organization whose core mission involves the diagnosis and treatment of allergic conditions. The practice operates a network of multiple offices, delivering specialized services to patients across various geographic locations. Its clinical focus encompasses common allergies such as those triggered by pollen, food, insects, and medications, providing care that includes immunotherapy, commonly known as allergy shots. This targeted specialization positions the organization within the broader healthcare sector, serving a specific patient population with chronic allergic diseases. The operational model relies on consistent, scheduled patient visits for ongoing treatment regimens, making service continuity critical for patient health outcomes.

The organization's operational resilience was notably tested by a significant ransomware incident on February 23, 2020. This cyberattack precipitated an eight-day total network outage, which immediately and severely disrupted clinical activities at its numerous offices. The outage directly prevented staff from administering critical, time-sensitive allergy shots to patients, highlighting the direct patient-care impact of such cybersecurity failures. The attack prompted a formal investigation by the Federal Bureau of Investigation, underscoring the incident's severity. The perpetrators demanded a ransom of $1.75 million, though at the time of reporting, no exfiltrated data had appeared for sale on dark web platforms. This event was part of a concerning trend, as it marked the second publicly disclosed ransomware attack on an allergy practice within a single week, though no direct link between the separate incidents was identified. The attack illustrates the acute vulnerability of specialized medical practices to disruptive cyber extortion, where the interruption of routine, life-maintaining therapies constitutes a primary point of leverage for attackers.